RA
TMO icon

Ruggaard & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Ruggaard & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-854
Closed -$420K – 132
2026
Q1 		$420K Buy
854
+6
+0.7% +$3.26K 0.17% 76
2025
Q4 		$492K Buy
848
+47
+6% +$26.6K 0.19% 69
2025
Q3 		$389K Buy
801
+1
+0.1% +$465 0.15% 81
2025
Q2 		$325K Sell
800
-115
-13% -$48.1K 0.13% 88
2025
Q1 		$455K Sell
915
-15
-2% -$8.12K 0.2% 66
2024
Q4 		$484K Sell
930
-157
-14% -$86.3K 0.21% 64
2024
Q3 		$673K Sell
1,087
-9
-0.8% -$5.33K 0.29% 44
2024
Q2 		$606K Sell
1,096
-15
-1% -$8.59K 0.28% 53
2024
Q1 		$646K Sell
1,111
-79
-7% -$44.3K 0.31% 46
2023
Q4 		$632K Buy
1,190
+43
+4% +$20.8K 0.33% 43
2023
Q3 		$581K Buy
1,147
+350
+44% +$187K 0.35% 43
2023
Q2 		$416K Buy
797
+91
+13% +$49.1K 0.24% 64
2023
Q1 		$407K Buy
+706
New +$398K 0.25% 62

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ruggaard & Associates's TMO Position: Q2 2026 in Review

Ruggaard & Associates sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 854 shares — an estimated $420K sold.

Ruggaard & Associates first reported a position in TMO in Q1 2023 and held it in 13 quarters. The position peaked at $673K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ruggaard & Associates reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Ruggaard & Associates sold 854 Thermo Fisher Scientific shares in Q2 2026, an estimated $420K.
  • Ruggaard & Associates first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 13 quarters.
  • Ruggaard & Associates's Thermo Fisher Scientific position peaked at $673K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ruggaard & Associates's 13F filing for Q2 2026, filed 17 Aug 2026.